Urteste S.A. (WSE:URT)

Poland flag Poland · Delayed Price · Currency is PLN
86.80
-0.40 (-0.46%)
Feb 7, 2025, 5:51 PM CET
-17.33%
Market Cap 125.46M
Revenue (ttm) n/a
Net Income (ttm) -3.37M
Shares Out 1.41M
EPS (ttm) -2.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18
Average Volume 131
Open 85.60
Previous Close 87.20
Day's Range 85.60 - 87.00
52-Week Range 73.00 - 112.50
Beta 0.17
RSI 45.35
Earnings Date Jan 27, 2025

About Urteste

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 20
Stock Exchange Warsaw Stock Exchange
Ticker Symbol URT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.